Published 10/19/2025
Biologics are transforming orthopaedic practice. From bone grafts to platelet-rich plasma and stem cells, these treatments — derived from substances naturally found in the body — offer new ways to help bones, muscles, tendons, and ligaments heal more effectively. Yet, with rapid growth comes uncertainty. What is regulated? What is backed by evidence? And most importantly, what does this mean for orthopaedic surgeons and their patients?
To help answer these questions, AAOS created the Biologics Dashboard as an exclusive, members-only resource designed to cut through the confusion and provide orthopaedic surgeons with clear, reliable information.
A practical tool for a complex space
The Biologics Dashboard brings clarity to a field often clouded by mixed messages, inconsistent evidence, and evolving regulatory requirements. This interactive online tool aggregates the latest information about biologic-based products, combining clinical evidence with current FDA guidance.
The result? A simple, searchable database that allows you to quickly assess the regulatory and evidence status of a product or intervention. With just a few clicks, you can filter by tissue type, graft type, processing method, and intended use to receive a snapshot of the most up-to-date information available.
To make navigation even easier, the dashboard uses a color-coded indicator system:
- Green: clear, FDA-recognized, or on-label use
- Yellow: areas of uncertainty or physician-directed discretion
- Red: not currently aligned with FDA regulatory criteria
This visual approach helps surgeons interpret the current landscape quickly and confidently.
Exclusive member value
The Biologics Dashboard is available only to AAOS members — a reflection of the Academy’s commitment to providing resources that directly support clinical decision-making. By reviewing and updating the content semiannually, the tool ensures that members always have access to the most current data, helping them deliver safe, effective, and compliant care.
Importantly, the presence of a product in the Dashboard does not indicate AAOS endorsement. Instead, it provides the regulatory and evidence-based context members need to evaluate products for themselves.
Why it matters
Orthobiologics are not just a trend — they are a growing part of modern orthopaedics. As new products emerge and federal guidance evolves, it can be challenging to keep pace. The Biologics Dashboard allows AAOS members to do just that: stay current, stay compliant, and stay confident.
By putting trusted, evidence-based information at your fingertips, the dashboard supports the Academy’s mission to advance orthopaedic care and empower surgeons to make the best decisions for their patients.
Access the Biologics Dashboard today and see how this member-exclusive tool can simplify your practice and strengthen your patient care.